[MYGN] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
10-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -28.22%
YoY- 25.13%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 196,900 196,500 177,500 186,500 190,500 193,300 183,500 4.80%
PBT 8,000 12,100 4,000 37,300 43,100 45,000 43,500 -67.62%
Tax 3,800 6,200 5,200 13,900 10,500 14,700 16,900 -62.98%
NP 4,200 5,900 -1,200 23,400 32,600 30,300 26,600 -70.75%
Tax Rate -47.50% -51.24% -130.00% -37.27% -24.36% -32.67% -38.85% -
Total Cost 192,700 190,600 178,700 163,100 157,900 163,000 156,900 14.67%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 2.13 3.00 -0.68 12.55 17.11 15.68 14.50 -72.12%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS 0.06 0.09 -0.02 0.33 0.49 0.43 0.39 -71.25%
EPS Diluted 0.06 0.09 -0.02 0.32 0.47 0.41 0.37 -70.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.